Kathy Q. Cai
Department of Cancer Research
Fox Chase Cancer Center
United States of America
Biography
Kathy Q. Cai,Educational Background: PhD, Fudan University, China, 2002 MD, Shanghai Medical University, China, 1994
Research Interest
Development and improvement of immunohistochemical (IHC, traditional and fluorescence-based) assays to detect and quantify important components of cell signaling pathways. Molecular mechanism of ovarian cancer initiation and development. Histopathology evaluation of rodent models of human cancer.
Publications
-
Lee, S. Y., Coffey, F., Fahl, S. P., Peri, S., Rhodes, M., Cai, K. Q., ... & Kappes, D. J. (2014). Noncanonical mode of ERK action controls alternative αβ and γδ T cell lineage fates. Immunity, 41(6), 934-946.
-
Cai, K. Q., Wang, Y., Smith, E. R., Smedberg, J. L., Yang, D. H., Yang, W. L., & Xu, X. X. (2015). Global Deletion of Trp53 Reverts Ovarian Tumor Phenotype of the Germ Cell–Deficient White Spotting Variant (Wv) Mice. Neoplasia, 17(1), 89-100.
-
Prudnikova, T. Y., Villamar-Cruz, O., Rawat, S. J., Cai, K. Q., & Chernoff, J. (2016). Effects of p21-activated kinase 1 inhibition on 11q13 amplified ovarian cancer cells. Oncogene, 35(17), 2178.
